UCL IoO Annual Award Lecture 2022
15 June 2022, 1:00 pm–2:00 pm
Professor Mike Sapieha from the University of Montreal, Canada will deliver the UCL IoO Annual Lecture for 2022.
This event is free.
- All | UCL staff | UCL students
IoO Lecture theatre11-43 Bath Street LondonLondonEC1V 9ELUnited Kingdom
The UCL Institute of Ophthalmology Annual Award Lecture was established in 2018 to honour scientists who have made outstanding contributions in the field of ophthalmology and visual science. The lecture is part of the IoO Day when awards are also given to IoO and Moorfields/IoO-associated staff to recognise and celebrate academic, teaching, collegiality and public-patient involvement and engagement (PPIE) activities from staff and students who have made significant contributions to the IoO.
- UCL IoO Day programme 2022
- Part of UCL IoO Week 2022
- Professor Mike (Przemyslaw) Sapieha's profile on Centre de recherche de l'Hôpital Maisonneuve-Rosemont's website
About the Speaker
Prof Mike (Przemyslaw) Sapieha
Wolfe Professor in Translational Vision Research at University of Montreal
Mike (Przemyslaw) Sapieha is the Wolfe Professor in Translational Vision Research at the University of Montreal and holds the Canada Research Chair in Retinal Cell Biology. His work focuses on identifying novel, druggable mechanisms for retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration. His lab has published articles in Science, Cell Metabolism, Science Translational Medicine, Journal of Clinical Investigation, PNAS and more.
He is the founder of the biotech company SemaThera Inc and the Chief Scientific Advisor of Unity Biotechnology in San Francisco. Mike received the 2019 Cogan Award from the Association for Research and Vision and Ophthalmology, the 2020 Alcon Senior Investigator Award and the 2022 Innovation Award in AMD from the Bright Focus Foundation. In 2018, he was elected to the College of the Royal Society of Canada.
The title of Professor Sapieha's talk for this lecture is: "Revascularizing the Ischemic Retina."More about Prof Mike (Przemyslaw) Sapieha